AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34071171 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent intervention (individual, group, and community interventions for 12 months)
Number of subjects: 694
Study 34071171 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent intervention
Number of subjects: 694
Study 34071171 — intervention group
Group type: COMPARATOR
Intervention: Usual health care (Control)
Number of subjects: 694
Study 35074896 — intervention group
Group type: EXPERIMENTAL
Intervention: Alteplase
Number of subjects: 0
Study 35074896 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32272249 — intervention group
Group type: EXPERIMENTAL
Intervention: Reflux hypersensitivity (RH) with excessive supragastric belching (SGB)
Number of subjects: 542
Study 32272249 — intervention group
Group type: EXPERIMENTAL
Intervention: Reflux hypersensitivity (RH) with rumination
Number of subjects: 542
Study 32272249 — intervention group
Group type: COMPARATOR
Intervention: Functional heartburn
Number of subjects: 542
Study 32272249 — intervention group
Group type: EXPERIMENTAL
Intervention: Reflux hypersensitivity (RH)
Number of subjects: 542
Study 35745216 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean Diet group weaned with fresh, seasonal, and tasty foods of Med Diet
Number of subjects: 394
Study 35745216 — intervention group
Group type: COMPARATOR
Intervention: Control group predominantly weaned with industrial baby foods
Number of subjects: 394
Study 35745216 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean Diet group
Number of subjects: 394
Study 33706344 — intervention group
Group type: EXPERIMENTAL
Intervention: Superior hypogastric plexus block
Number of subjects: 100
Study 33706344 — intervention group
Group type: COMPARATOR
Intervention: No superior hypogastric plexus block (Control)
Number of subjects: 100
Study 32119599 — intervention group
Group type: COMPARATOR
Intervention: C-IMRT (76 Gy in 38 fractions)
Number of subjects: 303
Study 32119599 — intervention group
Group type: EXPERIMENTAL
Intervention: H-IMRT (70.2 Gy in 26 fractions)
Number of subjects: 303
Study 32119599 — intervention group
Group type: COMPARATOR
Intervention: C-IMRT
Number of subjects: 303
Study 32119599 — intervention group
Group type: EXPERIMENTAL
Intervention: H-IMRT
Number of subjects: 303
Study 36250812 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased amputated-region sensitivity (n = 24)
Number of subjects: 99
Study 36250812 — intervention group
Group type: COMPARATOR
Intervention: Non-sensitive group (n = 36)
Number of subjects: 99
Study 36250812 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall participants with central sensitization symptoms
Number of subjects: 99
Study 32604068 — intervention group
Group type: EXPERIMENTAL
Intervention: Whey protein supplementation
Number of subjects: 101
Study 32604068 — intervention group
Group type: COMPARATOR
Intervention: Placebo supplementation
Number of subjects: 101
Study 37385337 — intervention group
Group type: EXPERIMENTAL
Intervention: Home spirometry
Number of subjects: 2857
Study 37385337 — intervention group
Group type: COMPARATOR
Intervention: Clinic spirometry
Number of subjects: 2857
Study 33484254 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise and Protein (Group A)
Number of subjects: 60
Study 33484254 — intervention group
Group type: EXPERIMENTAL
Intervention: Protein (Group B)
Number of subjects: 60
Study 33484254 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise (Group C)
Number of subjects: 60
Study 33484254 — intervention group
Group type: COMPARATOR
Intervention: Control (Group D)
Number of subjects: 60
Study 32312255 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-month course with the self-management package and a support session
Number of subjects: 50
Study 34009514 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium and Melatonin co-supplementation for 8 weeks
Number of subjects: 84
Study 34009514 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin for 8 weeks
Number of subjects: 84
Study 34009514 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium plus Melatonin for 8 weeks
Number of subjects: 84
Study 34009514 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 8 weeks
Number of subjects: 84
Study 34350897 — intervention group
Group type: EXPERIMENTAL
Intervention: Early steered stimulation
Number of subjects: 13
Study 34350897 — intervention group
Group type: COMPARATOR
Intervention: Delayed steered stimulation
Number of subjects: 13
Study 34350897 — intervention group
Group type: EXPERIMENTAL
Intervention: Early steered stimulation and Delayed steered stimulation
Number of subjects: 13
Study 34952736 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous tranexamic acid (TXA) 15 mg/kg
Number of subjects: 30
Study 34952736 — intervention group
Group type: COMPARATOR
Intervention: Placebo (10 ml saline)
Number of subjects: 30
Study 34487722 — intervention group
Group type: EXPERIMENTAL
Intervention: Start oral anticoagulation (101 participants)
Number of subjects: 203
Study 34487722 — intervention group
Group type: COMPARATOR
Intervention: Avoid oral anticoagulation (102 participants)
Number of subjects: 203
Study 616666876 — intervention group
Group type: EXPERIMENTAL
Intervention: hANP
Number of subjects: 286
Study 616666876 — intervention group
Group type: EXPERIMENTAL
Intervention: ARC (hANP + ARB)
Number of subjects: 286
Study 616666876 — intervention group
Group type: COMPARATOR
Intervention: Control (Placebo)
Number of subjects: 286
Study 35618748 — intervention group
Group type: EXPERIMENTAL
Intervention: Betamethasone
Number of subjects: 58
Study 35618748 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study 33152688 — intervention group
Group type: EXPERIMENTAL
Intervention: Standing desk
Number of subjects: 36
Study 33152688 — intervention group
Group type: COMPARATOR
Intervention: Seated desk
Number of subjects: 36
Study 35505437 — intervention group
Group type: EXPERIMENTAL
Intervention: Measurement-based care (MBC)
Number of subjects: 900
Study 35505437 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 900
Study 35505437 — intervention group
Group type: EXPERIMENTAL
Intervention: MBC
Number of subjects: 900
Study 35505437 — intervention group
Group type: COMPARATOR
Intervention: TAU
Number of subjects: 900
Study 32964986 — intervention group
Group type: EXPERIMENTAL
Intervention: VASPIN treatment
Number of subjects: 0
Study 32964986 — intervention group
Group type: EXPERIMENTAL
Intervention: VASPIN treatment in HK-2 cells
Number of subjects: 0
Study 36113532 — intervention group
Group type: EXPERIMENTAL
Intervention: One dose of 2-valent vaccine (Cervarix)
Number of subjects: 930
Study 36113532 — intervention group
Group type: EXPERIMENTAL
Intervention: One dose of 9-valent vaccine (Gardasil 9)
Number of subjects: 930
Study 34310978 — intervention group
Group type: EXPERIMENTAL
Intervention: TVB-2640 25 mg
Number of subjects: 99
Study 34310978 — intervention group
Group type: EXPERIMENTAL
Intervention: TVB-2640 50 mg
Number of subjects: 99
Study 34310978 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 99
Study 32691850 — intervention group
Group type: EXPERIMENTAL
Intervention: Eslicarbazepine acetate (ESL)
Number of subjects: 76
Study 34595801 — intervention group
Group type: EXPERIMENTAL
Intervention: Slow deep breathing (SDB) intervention, 20-minute video 5 times weekly for 4 weeks
Number of subjects: 14
Study 34595801 — intervention group
Group type: COMPARATOR
Intervention: Control group (normal activities)
Number of subjects: 14
Study 33891721 — intervention group
Group type: EXPERIMENTAL
Intervention: IPTp-DHP
Number of subjects: 956
Study 33891721 — intervention group
Group type: COMPARATOR
Intervention: IPTp-SP
Number of subjects: 956
Study 32858264 — intervention group
Group type: EXPERIMENTAL
Intervention: E-learning video curriculum for outpatient pediatric endocrinology rotation
Number of subjects: 41
Study 32858264 — intervention group
Group type: COMPARATOR
Intervention: Control group (no e-learning video curriculum)
Number of subjects: 41
Study 36171046 — intervention group
Group type: EXPERIMENTAL
Intervention: OnTrack intervention (12 weeks using the OnTrack system comprising arm tracking and coaching support for self-management)
Number of subjects: 12
Study 36171046 — intervention group
Group type: EXPERIMENTAL
Intervention: OnTrack intervention
Number of subjects: 12
Study 34856687 — intervention group
Group type: EXPERIMENTAL
Intervention: Rishulin
Number of subjects: 563
Study 34856687 — intervention group
Group type: COMPARATOR
Intervention: NovoRapid
Number of subjects: 563
Study 35686334 — intervention group
Group type: EXPERIMENTAL
Intervention: AFP ratio <37.9 (high-risk group)
Number of subjects: 368
Study 35686334 — intervention group
Group type: COMPARATOR
Intervention: AFP ratio >37.9 (low-risk group)
Number of subjects: 368
Study 32720602 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin (40 mg/day) + Ezetimibe (10 mg/day)
Number of subjects: 18144
Study 32720602 — intervention group
Group type: COMPARATOR
Intervention: Simvastatin (40 mg/day) monotherapy
Number of subjects: 18144
Study 32202256 — intervention group
Group type: EXPERIMENTAL
Intervention: Lopinavir/ritonavir combination therapy for 14 days
Number of subjects: 0
Study 36031718 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 g/kg ethanol
Number of subjects: 29
Study 36031718 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 g/kg ethanol
Number of subjects: 29
Study 36031718 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study 33455765 — intervention group
Group type: EXPERIMENTAL
Intervention: Propylene glycol (PG) at 15.0 μL/g of dry matter (TRT)
Number of subjects: 4
Study 33455765 — intervention group
Group type: COMPARATOR
Intervention: Control group (0 μL/g of dry matter, CON)
Number of subjects: 4
Study 32337700 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose nalmefene (N1 group, n=40)
Number of subjects: 120
Study 32337700 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose nalmefene (N2 group, n=40)
Number of subjects: 120
Study 32337700 — intervention group
Group type: COMPARATOR
Intervention: Control group (physiologic saline, n=40)
Number of subjects: 120
Study 32337700 — intervention group
Group type: COMPARATOR
Intervention: Control group (physiologic saline)
Number of subjects: 120
Study 32337700 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose nalmefene (N1 group)
Number of subjects: 120
Study 32337700 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose nalmefene (N2 group)
Number of subjects: 120
Study 35090675 — intervention group
Group type: EXPERIMENTAL
Intervention: eRegistry with clinical decision support
Number of subjects: 6367
Study 35090675 — intervention group
Group type: COMPARATOR
Intervention: Paper-based documentation
Number of subjects: 6367
Study 33910605 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP) application during ACL surgery
Number of subjects: 34
Study 33910605 — intervention group
Group type: COMPARATOR
Intervention: Control group without PRP application
Number of subjects: 34
Study 32876468 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture treatment (n=25)
Number of subjects: 50
Study 32876468 — intervention group
Group type: COMPARATOR
Intervention: Mock transcutaneous electrical nerve stimulation and sham acupuncture (n=25)
Number of subjects: 50
Study 36041396 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.45 mg/kg selenium-enriched yeast (SeY)
Number of subjects: 36
Study 36041396 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 36
Study 33905907 — intervention group
Group type: COMPARATOR
Intervention: Standard pterional approach (PtA)
Number of subjects: 111
Study 33905907 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive surgery (MIS) - transeyelid approach (TelA)
Number of subjects: 111
Study 33905907 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive surgery (MIS) - nanopterional approach (NPtA)
Number of subjects: 111
Study 33905907 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive surgery (MIS)
Number of subjects: 111
Study 32438659 — intervention group
Group type: EXPERIMENTAL
Intervention: Gradually salt-reduced bread
Number of subjects: 309
Study 32438659 — intervention group
Group type: COMPARATOR
Intervention: Gradually salt-reduced bread and dietary counselling
Number of subjects: 309
Study 32438659 — intervention group
Group type: COMPARATOR
Intervention: Standard bread (control)
Number of subjects: 309
Study 35861901 — intervention group
Group type: EXPERIMENTAL
Intervention: PRINT group (modified PVI line according to esophageal fingerprint)
Number of subjects: 60
Study 35861901 — intervention group
Group type: COMPARATOR
Intervention: CONTROL group (standard PVI with operator blinded to the fingerprint)
Number of subjects: 60
Study 35861901 — intervention group
Group type: EXPERIMENTAL
Intervention: PRINT group
Number of subjects: 60
Study 35861901 — intervention group
Group type: COMPARATOR
Intervention: CONTROL group
Number of subjects: 60
Study 34867233 — intervention group
Group type: EXPERIMENTAL
Intervention: Insight Questions Inventory (IQI) and Visual Support Strategies (IQI VSS)
Number of subjects: 191
Study 34867233 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy for CP
Number of subjects: 191
Study 32906138 — intervention group
Group type: EXPERIMENTAL
Intervention: iStent implantation and cataract surgery
Number of subjects: 80
Study 32906138 — intervention group
Group type: COMPARATOR
Intervention: Phacoemulsification alone (control group)
Number of subjects: 80
Study 35637515 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction (MBSR) program for 2.5 hours weekly for 8 weeks
Number of subjects: 40
Study 35637515 — intervention group
Group type: COMPARATOR
Intervention: Usual care management
Number of subjects: 40
Study 33243368 — intervention group
Group type: EXPERIMENTAL
Intervention: e-coachER intervention
Number of subjects: 450
Study 33243368 — intervention group
Group type: COMPARATOR
Intervention: Control group (exercise referral schemes alone)
Number of subjects: 450
Study 33434080 — intervention group
Group type: EXPERIMENTAL
Intervention: Fortified low-fat yogurt (1500 IU nano encapsulated vitamin D3 per 150 g/d)
Number of subjects: 306
Study 33434080 — intervention group
Group type: EXPERIMENTAL
Intervention: Fortified low-fat milk (1500 IU nano encapsulated vitamin D3 per 200 g/d)
Number of subjects: 306
Study 33434080 — intervention group
Group type: COMPARATOR
Intervention: Fortified low-fat milk
Number of subjects: 306
Study 33434080 — intervention group
Group type: COMPARATOR
Intervention: Fortified low-fat yogurt and fortified low-fat milk
Number of subjects: 306
Study 32423935 — intervention group
Group type: EXPERIMENTAL
Intervention: Salt Control H (innovative prototype equipment to monitor and control use of salt when cooking)
Number of subjects: 260
Study 32423935 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 260
Study 35788492 — intervention group
Group type: EXPERIMENTAL
Intervention: upadacitinib 15 mg once daily
Number of subjects: 420
Study 35788492 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 420
Study 32412597 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole roasted almonds
Number of subjects: 107
Study 32412597 — intervention group
Group type: COMPARATOR
Intervention: Control snacks (mini-muffins)
Number of subjects: 107
Study 34245981 — intervention group
Group type: EXPERIMENTAL
Intervention: Prior eating disorder (ED) diagnosis
Number of subjects: 159
Study 34245981 — intervention group
Group type: COMPARATOR
Intervention: General population (non-ED group)
Number of subjects: 159
Study 32167784 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct Service Model (6 sessions over 22 weeks of pharmacotherapy followed by behavior training)
Number of subjects: 223
Study 32167784 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct Service Model
Number of subjects: 223
Study 32167784 — intervention group
Group type: COMPARATOR
Intervention: Consultation Model (single-session consultation)
Number of subjects: 223
Study 36115963 — intervention group
Group type: EXPERIMENTAL
Intervention: TransformUs intervention
Number of subjects: 407
Study 34112322 — intervention group
Group type: EXPERIMENTAL
Intervention: Strategies to end gender inequality in cardiovascular clinical trial leadership
Number of subjects: 10
Study 35503446 — intervention group
Group type: EXPERIMENTAL
Intervention: Capsaicin (1.5 μg)
Number of subjects: 29
Study 35503446 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study 33882541 — intervention group
Group type: EXPERIMENTAL
Intervention: High Dose TXA (30 mg/kg loading dose followed by 10 mg/kg/h infusion)
Number of subjects: 166
Study 33882541 — intervention group
Group type: EXPERIMENTAL
Intervention: Low Dose TXA (10 mg/kg loading dose followed by 1 mg/kg/h infusion)
Number of subjects: 166
Study 33882541 — intervention group
Group type: COMPARATOR
Intervention: High Dose TXA
Number of subjects: 166
Study 33882541 — intervention group
Group type: COMPARATOR
Intervention: Low Dose TXA
Number of subjects: 166
Study 35131133 — intervention group
Group type: EXPERIMENTAL
Intervention: BNT162b2 mRNA COVID-19 vaccine
Number of subjects: 3813
Study 35131133 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3813
Study 32607749 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose IL-2 (0.125, 0.250, or 0.500 million international units (MIU)/m2, given daily for 5 days and then fortnightly for 1 year)
Number of subjects: 24
Study 32607749 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 32607749 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose IL-2 (0.250 and 0.500 MIU m−2 day−1)
Number of subjects: 24
Study 35543439 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug-coated balloon (DCB)
Number of subjects: 256
Study 35543439 — intervention group
Group type: COMPARATOR
Intervention: Plain balloon angioplasty
Number of subjects: 256
Study 33232472 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous transplantation planned group
Number of subjects: 2334
Study 33232472 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-transplant planned group
Number of subjects: 2334
Study 33232472 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with improved renal function
Number of subjects: 2334
Study 33232472 — intervention group
Group type: EXPERIMENTAL
Intervention: Current therapies
Number of subjects: 2334
Study 33232472 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with high free light chain at baseline
Number of subjects: 2334
Study 36350332 — intervention group
Group type: EXPERIMENTAL
Intervention: Gamified mobile application for somatosensory training (daily use for 4 weeks)
Number of subjects: 35
Study 36350332 — intervention group
Group type: COMPARATOR
Intervention: Control phase (no use of the new system for 4 weeks)
Number of subjects: 35
Study 33907260 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-stroke physical activity after 6 months
Number of subjects: 49
Study 33907260 — intervention group
Group type: COMPARATOR
Intervention: Pre-stroke physical activity
Number of subjects: 49
Study 33559636 — intervention group
Group type: EXPERIMENTAL
Intervention: Incisional Negative Pressure Wound Therapy (INPWT)
Number of subjects: 65
Study 33559636 — intervention group
Group type: COMPARATOR
Intervention: Conventional dressing
Number of subjects: 65
Study 36517290 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 260
Study 36517290 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 260
Study 34255680 — intervention group
Group type: EXPERIMENTAL
Intervention: Home Exercise Program (HEP) delivered via telerehabilitation, 12 weeks duration, performed 2.04 times per week (95% CI 1.25‐4.08).
Number of subjects: 11
Study 33414824 — intervention group
Group type: EXPERIMENTAL
Intervention: BCI group (motor imagery-based brain-computer interface with functional electrical stimulation)
Number of subjects: 16
Study 33414824 — intervention group
Group type: COMPARATOR
Intervention: Control group (traditional rehabilitation therapy)
Number of subjects: 16
Study 35341629 — intervention group
Group type: EXPERIMENTAL
Intervention: Suture anchor repair
Number of subjects: 60
Study 35341629 — intervention group
Group type: COMPARATOR
Intervention: Transosseous sutures
Number of subjects: 60
Study 32811160 — intervention group
Group type: EXPERIMENTAL
Intervention: ImPACT intervention strategies
Number of subjects: 97
Study 32811160 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 97
Study 35222903 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotinamide 1000 mg once daily for 12 weeks
Number of subjects: 70
Study 35222903 — intervention group
Group type: COMPARATOR
Intervention: Control group (antidiabetic therapy only)
Number of subjects: 70
Study 35594970 — intervention group
Group type: EXPERIMENTAL
Intervention: Online cognitive behavior therapy (CBT) program with 8 modules and 8, 30-minute telephone sessions with a therapist (n = 45)
Number of subjects: 91
Study 35594970 — intervention group
Group type: COMPARATOR
Intervention: Wait control group (n = 46)
Number of subjects: 91
Study 33131927 — intervention group
Group type: EXPERIMENTAL
Intervention: Enriched report informed by best practices
Number of subjects: 470
Study 33131927 — intervention group
Group type: COMPARATOR
Intervention: Standard CPMC report
Number of subjects: 470
Study 33032546 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (N = 55)
Number of subjects: 184
Study 33032546 — intervention group
Group type: COMPARATOR
Intervention: Control group (N = 54)
Number of subjects: 184
Study 33032546 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 184
Study 36171040 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated GP-paediatrician model of care (weekly co-consultation sessions, monthly case discussions, phone and email support)
Number of subjects: 22
Study 36171040 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated GP-paediatrician model of care
Number of subjects: 22
Study 36171040 — intervention group
Group type: EXPERIMENTAL
Intervention: Implementation evaluation of the model
Number of subjects: 22
Study 36171040 — intervention group
Group type: EXPERIMENTAL
Intervention: Health economic evaluation
Number of subjects: 22
Study 33533682 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality Training
Number of subjects: 32
Study 33533682 — intervention group
Group type: COMPARATOR
Intervention: Traditional Exercise Program
Number of subjects: 32
Study 32085929 — intervention group
Group type: EXPERIMENTAL
Intervention: Microdebrider assisted turbinoplasty (MAT)
Number of subjects: 33
Study 32085929 — intervention group
Group type: EXPERIMENTAL
Intervention: Coblation assisted turbinoplasty (CAT)
Number of subjects: 33